Securities code: 002675 securities abbreviation: Yantai Dongcheng Biochemicals Co.Ltd(002675) Announcement No.: 2022-007 Yantai Dongcheng Biochemicals Co.Ltd(002675)
Notice on the first feedback opinions of the CSRC on the examination of administrative licensing projects
Announcement of response to feedback
The company and all members of the board of directors guarantee that the information disclosed is true, accurate and complete
False records, misleading statements or material omissions.
Yantai Dongcheng Biochemicals Co.Ltd(002675) (hereinafter referred to as the “company”) received the notice of the CSRC on the first feedback on the examination of administrative licensing projects (acceptance No.: 213594) (hereinafter referred to as the “feedback”) issued by the China Securities Regulatory Commission (hereinafter referred to as the “CSRC”) on January 28, 2022. The company and relevant intermediaries have carefully studied and implemented the feedback, supplemented the information and replied to the questions related to the matters in accordance with the requirements of the feedback, and now publicly disclose the reply to the feedback as required, For details, please refer to the reply on the feedback on Yantai Dongcheng Biochemicals Co.Ltd(002675) 2021 A-share application documents of non-public development banks published on cninfo.com on the same day. The company will submit feedback reply materials to the CSRC within 2 working days after the above feedback reply disclosure.
The company’s non-public offering of A-Shares needs further approval from the CSRC, and there is still uncertainty about whether it can be approved. According to the progress of the matter, the company will timely perform the obligation of information disclosure in strict accordance with the provisions and requirements of relevant laws and regulations. Please pay attention to the investment risks.
It is hereby announced.
Yantai Dongcheng Biochemicals Co.Ltd(002675) board of directors February 26, 2022
